| Net Cash Provided by (Used in) Operating Activities |
104M |
USD |
+52.2% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-98.6M |
USD |
-220% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
108M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
63.7M |
USD |
+2.81% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
27.1M |
USD |
+6.8% |
Q1 2025 |
Q1 2025 |
| Deferred Income Tax Expense (Benefit) |
378K |
USD |
-88.2% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
-73K |
USD |
-120% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
2M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
1.37B |
USD |
-2.33% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
125M |
USD |
+19.5% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |